Relief Therapeutics Holding: Swiss Biopharma Innovator Targeting Rare Diseases
Relief Therapeutics Holding AG: Swiss biopharma focused on rare metabolic, pulmonary, and connective tissue disorders, trading on SIX with a $28M market cap.
- MINDMAZE THERAPEUTICS HOLDIN
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read